Client Result
Orrick Advises Green Street Power Partners on Sale of Majority Stake
2 minute read | April.12.2023

2 minute read | April.12.2023
1 minute read | December.20.2022
June.27.2022
The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.
June.06.2022
April.27.2022
December.22.2021
October.04.2021
Congratulations to our client Ladder, a digital life insurance company, on its $100 million Series D financing round.
September.24.2021
September.10.2021